[Intense-pulse-light therapy treatment for dry eye syndrome]

Colaci C, Pichon-Riviere A, Argento F, Alfie V, Ciapponi A, Bardach A, García Martí S, Alcaraz A, Augustovski F
Record ID 32018004396
Original Title: Luz pulsada intensa para el síndrome de ojo seco
Authors' recommendations: Low-quality evidence suggests that intense pulsed light therapy treatment for the dry eye disease caused by meibomiam gland dysfunction might slightly improve the quality of tears, but it did not show any benefit in dry eye symptoms. There is no evidence that its effects maintain at long term. The American Ophthalmology Academy considers it as a second-line alternative. No local or international guidelines mentioning its use for this condition have been found. Its use for this indication has been recently approved by the United States regulatory agency, but not by the European Union. In Argentina, the use of intense pulsed light has been approved by the ANMAT just for skin conditions but not for the treatment of dry eye disease. No coverage policies covering the use of intense pulsed light for this indication have been found. Aetna, the US private health insurance company, considers this is a technology at investigational stage for this indication and does not cover it. No local or international economic evaluations related to the cost-effectiveness of the use of intense pulsed light for this indication have been found.
Project Status: Completed
Year Published: 2021
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Dry Eye Syndromes
  • Low-Level Light Therapy
  • Intense Pulsed Light Therapy
  • Meibomian Gland Dysfunction
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.